3 completed, 1 active not recruiting, 1 unknown. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Neovascularization: new trials by email Literature Review of Neovascularization trials Research Report on Neovascularization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever Tigertriever 13 - Ischemic Stroke, Neovascularization | Not applicable | Completed | Rapid Medical | 149 | 2022-03-25 | 2026-08-12 |
| KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial 4mg/ml KDR2-2 suspension eyedrop, 16mg/ml KDR2-2 suspension eyedrop - Neovascular Glaucoma, Neovascularization | Phase 1 | Active not recruiting | Sun Yat-sen University | 40 | 2021-04-19 | 2024-12-11 |
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection ziv-aflibercept - Neovascularization, Macular Degeneration | Phase 2 | Unknown | Rafic Hariri University Hospital | 100 | 2015-03-01 | 2018-08-29 |
| Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth Ranibizumab - Neovascularization | Phase 1 | Completed | National Eye Institute (NEI) | 1 | 2008-05-21 | 2017-07-02 |
| Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Neovascularization, Tuberculosis | Completed | Rafic Hariri University Hospital | 100 | 2007-01-01 | 2008-03-28 |
Neovascularization, Pathologic (5) · Choroidal Neovascularization (1) · Diabetic Retinopathy (1) · Glaucoma, Neovascular (1) · Histoplasmosis (1) · Ischemic Stroke (1) · Macular Degeneration (1) · Macular Edema (1) · Pterygium (1) · Retinal Neovascularization (1) · Retinal Vein Occlusion (1) · Tuberculosis (1)
Metaplasia (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Cardiovascular Diseases (2) · Eye Diseases (2) · Vascular Diseases (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Choroid Diseases (1) · Conjunctival Diseases (1) · Diabetes Complications (1)
Ranibizumab (1) · aflibercept (1)
Rafic Hariri University Hospital (2) · National Eye Institute (NEI) (1) · Rapid Medical (1) · Sun Yat-sen University (1)
Lebanon (2) · United States (2) · Belgium (1) · China (1) · Germany (1) · Sweden (1)
Ahmad M Mansour, MD (2) · Xiulan Zhang, MD, PhD (1)
PMID 18619571, PMID 19427992, PMID 22687305, PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432